Online citations, reference lists, and bibliographies.
← Back to Search

Preparation And Characterization Of Microspheres Containing The Anti-inflammatory Agents, Indomethacin, Ibuprofen, And Ketoprofen

R. Bodmeier, H. Chen
Published 1989 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract The anti-inflammatory agents, indomethacin, ibuprofen, and ketoprofen, were encapsulated by the solvent evaporation method using polymers such as ethylcellulose, poly(ϵ-caprolactone), poly(methyl methacrylate), polystyrene, and Eudragit RS and RL. In vitro dissolution studies, scanning electron microscopy, and differential scanning calorimetry were used to characterize the microspheres. In contrast to the release of ibuprofen and ketoprofen, the release of indomethacin from ethylcellulose microspheres was too slow for oral use even at high drug loadings. The indomethacin release could be increased by using more permeable polymers or polymer blends. The rates of polymer and drug precipitation during microsphere formation were dependent upon the organic solvent selected. When chloroform was selected as the organic solvent, the drug precipitated before the polymer and indomethacin crystals were visible on the microsphere surface. With methylene chloride, the polymer precipitated before the drug, and drug crystals were not observed. The analysis of the microspheres by differential scanning calorimetry was inconclusive since the drugs dissolved in the molten polymer during the heating step. Indomethacin-poly(ϵ-caprolactone) microspheres were prepared by a melt-dispersion technique without the use of organic solvents.
This paper references
Microencapsulation and related drug processes
P. Deasy (1984)
10.1002/JPS.2600750905
5-Fluorouracil:carnauba wax microspheres for chemoembolization: an in vitro evaluation.
S. Benita (1986)
10.1002/JPS.2600680318
Sustained release of drugs from ethylcellulose--polyethylene glycol films and kinetics of drug release.
Y. Samuelov (1979)
10.1016/0168-3659(87)90074-5
Prolonged delivery of peptides by microcapsules
H. V. Maulding (1987)
10.1002/JBM.820130313
Sustained drug delivery systems. I. The permeability of poly(ϵ-caprolactone), poly(DL-lactic acid), and their copolymers
C. Pitt (1979)
Microcapsule processing and technology
A. Kondō (1979)
10.3109/02652048709021820
Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.
R. Bodmeier (1987)
10.1016/0168-3659(87)90033-2
Polyanhydride microspheres as drug carriers I. Hot-melt microencapsulation
E. Mathiowitz (1987)
10.1248/CPB.29.3363
Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.
N. Wakiyama (1981)
10.1097/00000542-194105000-00013
The Pharmacological Basis of Therapeutics
L. Goodman (1941)
10.1007/978-1-4684-7744-3_18
Controlled Release of Biologically Active Agents
S. Yolles (1975)
10.1016/S0015-0282(16)44002-1
A new long-acting injectable microcapsule system for the administration of progesterone.
L. Beck (1979)
10.1248/CPB.34.2618
Preparation and dissolution pattern of Eudragit RS microcapsules containing ketoprofen.
M. Kawata (1986)
10.1016/0378-5173(86)90106-7
A physicochemical study of the morphology of progesterone-loaded poly (d,l-lactide) microspheres
J. Benoît (1986)
10.3109/03639048709068375
Control of Drug Release Rate by Use of Mixtures of Polycaprolactone and Cellulose Acetate Butyrate Polymers
Rong-Kun Chang (1987)
10.1016/0378-5173(88)90073-7
Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method
R. Bodmeier (1988)
10.1002/JPS.2600630325
Quantitative analytical method for determination of drugs dispersed in polymers using differential scanning calorimetry.
F. Theeuwes (1974)
10.1002/POL.1969.160070505
Lactone polymers. I. Glass transition temperature of poly‐ε‐caprolactone by means on compatible polymer mixtures
J. Koleske (1969)
10.1002/JPS.2600750407
Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer.
L. M. Sanders (1986)



This paper is referenced by
10.1016/j.nano.2009.09.002
Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery.
Swarnali Das (2010)
10.1080/026520401750038647
Spray-dried microspheres containing ketoprofen formulated into capsules and tablets.
M. Moretti (2001)
10.3109/02652049109071487
Poly(hydroxybutyrate-hydroxyvalerate) microspheres containing progesterone: preparation, morphology and release properties.
N. Gangrade (1991)
10.1016/j.nano.2010.07.003
Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B.
Swarnali Das (2011)
10.1016/j.jddst.2020.102145
Surface Modification of PLGA Nanoparticles with Chitosan or Eudragit® RS 100: Characterization, prolonged release, cytotoxicity, and enhanced antimicrobial activity
Gülsel Yurtdaş-Kırımlıoğlu (2020)
10.7897/2230-8407.096103
TOLNAFTATE MICROSPONGES EMBEDDED BIOCOMPATIBLE GELS FOR CONTROLLED AND EFFECTIVE ANTIDERMATOPHYTIC ACTIVITY
Prashant Pandey (2018)
10.1080/10837450.2018.1455697
Antioxidant activity and photostability assessment of trans-resveratrol acrylate microspheres
R. Pignatello (2019)
10.1021/acs.langmuir.7b03574
Fast and Environmentally Friendly Microfluidic Technique for the Fabrication of Polymer Microspheres.
Y. Zhang (2017)
10.1016/S0378-5173(00)00379-3
Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules.
M. Cuña (2000)
10.1016/0378-5173(96)04560-7
Interaction between nicardipine hydrochloride and polymeric microspheres for a controlled release system
N. Yuksel (1996)
Preparation of poly (epsilon-caprolactone) microspheres containing etoposide by solvent evaporation method
M. Dhanaraju (2010)
10.1016/J.JCONREL.2004.03.023
Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.
N. Ubrich (2004)
10.1080/02652040010019488
Study of processing parameters influencing the properties of Diltiazem hydrochloride microspheres
S. S. Bhalerao, J. K. Lalla, M. S. Rane (2001)
10.1016/S0014-827X(03)00070-3
In vitro drug liberation and kinetics of sustained release indomethacin suppository.
G. Uzunkaya (2003)
Formulation and Evaluation of Gastroretentive Floating Microballoons of Anti diabetic drug
A. Yadav (2011)
10.1016/j.ijpharm.2020.119800
On-line dissolution analysis of multiple drugs encapsulated in electrospun nanofibers.
Zhongmei Chi (2020)
10.7324/JAPS.2017.70128
Design, Development and Characterization of Valsartan Microsponges by Quasi Emulsion Technique and the Impact of Stirring Rate on Microsponge Formation
Madhuri Desavathu (2017)
10.1155/2013/576370
Modified Chitosan-Clay Nanocomposite as a Drug Delivery System Intercalation and In Vitro Release of Ibuprofen
Rehab Abdeen (2013)
10.1208/ps050213
Wet granulation fine particle ethylcellulose tablets: Effect of production variables and mathematical modeling of drug release
A. Agrawal (2008)
Synthèse et caractérisation d'un hydrogel d'alginamide pour la régénération de voies nerveuses lésées au sein du Système Nerveux Central chez le rat
F. Vallée (2007)
MICROSPONGE: COMPREHENSIVE REVIEW OF APPLICATION
Swati Kale Valmik (2013)
10.1016/0040-6031(94)01947-F
Thermoanalysis of microspheres
C. Dubernet (1995)
10.1016/0378-5173(95)00060-V
Ethylcellulose matrix controlled release tablets of a water-soluble drug
Pruthvipathy R. Katikaneni (1995)
FLOATING MICROSPHERE: A NOVEL GASTRORETENTIVE DOSAGE FORM
Shaikh Salman Shaikh Ismail (2016)
10.1002/jps.22572
In-process crystallization of acidic drugs in acrylic microparticle systems: influence of physical factors and drug-polymer interactions.
M. A. Alhnan (2011)
10.1016/j.ijpharm.2008.10.037
Effects of process parameters on the properties of biocompatible ibuprofen-loaded microcapsules.
P. Valot (2009)
Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
Shefaatullah Shah (2012)
3D printing of medical device prototypes
J. Holländer (2014)
10.1016/0168-3659(90)90103-Z
Indomethacin polymeric nanosuspensions prepared by microfujidization
R. Bodmeier (1990)
10.4314/TJPR.V4I1.14622
Formulation and in vitro Evaluation of Eudragit ® Microspheres of Stavudine
S. Sahoo (2007)
10.22377/AJP.V6I1.75
Formulation and evaluation of dorzolamide hydrochloride-loaded nanoparticles as controlled release drug delivery system
Azza A. Hasan (2012)
Formulation and in vitro Evaluation of Eudragit ® Microspheres of Stavudine Sunit
K. Sahoo (2006)
See more
Semantic Scholar Logo Some data provided by SemanticScholar